Venditti, A., Peter Gale, R., Buccisano, F., Ossenkoppele, G. (2020). Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?. LEUKEMIA [10.1038/s41375-020-0780-6].
Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?
Venditti, Adriano
;Buccisano, Francesco;
2020-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
